Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2019-08-21 Report Publication Anno…
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Navamedic ASA: Invitation to second quarter presentation
Report Publication Announcement Classification · 96% confidence The document is titled 'Navamedic ASA: Invitation to second quarter presentation' and explicitly invites stakeholders to an event where the 'second quarter 2019 figures' will be presented. It provides the time, location, and webcast details for this presentation. This is not the full financial report (IR) itself, nor is it a transcript (CT). It is an announcement about an upcoming event where results will be discussed, which strongly aligns with the purpose of an Earnings Release (ER) announcement or, more broadly, a Call Transcript (CT) announcement if the presentation is the primary event. However, since it is an invitation to the presentation of results, and not the results themselves, it functions as a precursor announcement. Given the options, an invitation to an earnings presentation is most closely related to the Earnings Release (ER) process, but since it is an invitation to the *presentation* event, and not the release of the figures themselves, it fits best under the general category of an announcement related to financial reporting events. Since it is an invitation to a presentation, and not the actual transcript or the full report, and it is not explicitly announcing the *release* of a document, I will classify it based on the event it promotes. The closest fit among the specific codes is ER (Earnings Release), as this presentation is the mechanism for discussing the quarterly results. If the document were only announcing the publication of the Q2 report, RPA would be better. Since it's an invitation to the presentation event, ER is the most contextually appropriate choice, although it is an invitation rather than the release itself.
2019-08-21 English
NAVAMEDIC ASA: Minutes of Extraordinary General Meeting
AGM Information Classification · 98% confidence The document is explicitly titled "PROTOKOLL FRA EKSTRAORDINÆR GENERALFORSAMLING" (Minutes of Extraordinary General Meeting) in Norwegian and "MINUTES OF EXTRAORDINARY GENERAL MEETING" in English. It details the proceedings, attendees, votes, and resolutions passed during a formal shareholder meeting, including the approval of a demerger plan. This content directly corresponds to the documentation generated following a general meeting, which falls under the scope of AGM-R (AGM Information/Minutes), even though it is an Extraordinary General Meeting (EGM) rather than the Annual General Meeting (AGM). Since the definition for AGM-R covers presentations and materials shared during the AGM, and this is the official record of an EGM, AGM-R is the most appropriate classification among the choices provided, as there is no specific EGM code. It is the official record/protocol, not just an announcement of the meeting.
2019-08-05 Norwegian
NAVAMEDIC ASA: Minutes of Extraordinary General Meeting
AGM Information Classification · 95% confidence The document is explicitly titled 'Minutes of Extraordinary General Meeting' and discusses the adoption of proposals, including a demerger plan, during a meeting held on August 5, 2019. This content directly relates to the proceedings and outcomes of a shareholder meeting. While it mentions minutes are 'attached hereto', the core content is the summary of the meeting's decisions, which aligns best with AGM Information (AGM-R), as an Extraordinary General Meeting (EGM) is a type of general meeting. It is not a formal DEF 14A (Remuneration) or DVA (Declaration of Voting Results), but rather the record of the meeting itself.
2019-08-05 English
Navamedic is launching Alflorex in Norway
Regulatory Filings Classification · 100% confidence The document is a short press release dated August 5th, 2019, announcing a specific business event: the launch of the product Alflorex in Norway and the company's rights in Denmark and Iceland. It contains quotes from the CEO regarding growth strategy and product details. This type of announcement, which details a specific operational or commercial update (product launch, partnership expansion) that doesn't fit neatly into financial reporting (10-K, ER, IR) or governance (DEF 14A, DVA), is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if it were about fundraising, but here it is purely operational news. Since RNS is the fallback for miscellaneous regulatory announcements that aren't covered by the specific codes, and this is a standard press release format, RNS is the most appropriate classification.
2019-08-05 English
NAVAMEDIC ASA: Notice of Extraordinary General Meeting
AGM Information Classification · 98% confidence The document is titled "INNKALLING TIL EKSTRAORDINÆR GENERALFORSAMLING" (NOTICE OF EXTRAORDINARY GENERAL MEETING) for Navamedic ASA. It details the date, time, location, and agenda for a meeting where shareholders will vote on significant corporate actions, specifically a demerger and merger proposal, capital decrease, and amendments to the articles of association. It also includes instructions for attendance and proxy submission. This content directly relates to the formal procedures and materials required for a shareholder meeting, making it an AGM-related document. Since it is a notice/invitation to an Extraordinary General Meeting (EGM), the most appropriate classification among the provided options is AGM-R (AGM Information), as EGMs follow similar procedural documentation standards as AGMs, and this document serves as the primary notice material.
2019-06-28 Norwegian
NAVAMEDIC ASA: Notice of Extraordinary General Meeting
M&A Activity Classification · 99% confidence The document is explicitly titled "FISJONSPLAN" (Demerger Plan) and its English translation is "DEMERGER PLAN". This document details the legal and financial structure for the demerger of Navamedic ASA and merger with Observe Medical ASA. This type of corporate restructuring document, which outlines the terms of a major transaction involving the company's structure and assets, fits best under the category for Merger & Acquisition Activity (TAR), as a demerger is a form of corporate reorganization often related to M&A. It is not an Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or a simple announcement (RPA/RNS) because it is the comprehensive plan document itself, not just a notice that a report is available. Since 'TAR' covers 'merger proposals or takeover bids', a demerger plan is closely related to this category of significant corporate transactions.
2019-06-28 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.